Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality.
about
Is albuminuria screening and treatment optimal in patients with type 2 diabetes in primary care? Observational data of the GIANTT cohort.Why 24-h Urine Albumin Excretion Rate Method Still is Used for Screening of Diabetic Nephropathy in Isfahan Laboratories?Interaction of obesity and central obesity on elevated urinary albumin-to-creatinine ratio.Reference data for the Ruff Figural Fluency Test stratified by age and educational level.Early renal abnormalities in autosomal dominant polycystic kidney disease.Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney diseaseEstimated albumin excretion rate versus urine albumin-creatinine ratio for the assessment of albuminuria: a diagnostic test study from the Prevention of Renal and Vascular Endstage Disease (PREVEND) Study.New role for plasmin in sodium homeostasis.Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study.The association of APOE genotype with cognitive function in persons aged 35 years or older.Comparison of different measures of urinary protein excretion for prediction of renal events.The association of albuminuria with tubular reabsorption of uric acid: results from a general population cohortApolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein.Relevance to home blood pressure monitoring protocol of blood pressure measurements taken before first- morning micturition and in the afternoon.Urinary albumin excretion and prevalence of microalbuminuria in a general Chinese population: a cross-sectional study.Influence of age and measure of eGFR on the association between renal function and cardiovascular events.Liver function tests and risk prediction of incident type 2 diabetes: evaluation in two independent cohorts.Apolipoprotein B attenuates albuminuria-associated cardiovascular disease in prevention of renal and vascular endstage disease (PREVEND) participants.Predictors of progression in albuminuria in the general population: results from the PREVEND cohort.Statin use and cognitive function: population-based observational study with long-term follow-upAssociation of cognitive function with albuminuria and eGFR in the general population.The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older.Bilirubin as a potential causal factor in type 2 diabetes risk: a Mendelian randomization study.Number and frequency of albuminuria measurements in clinical trials in diabetic nephropathy.A Comparative Study of Clinical Utility of Spot Urine Samples with 24-h Urine Albumin Excretion for Screening of Microalbuminuria in Type 2 Diabetic Patients.Longitudinal study of performance on the Ruff Figural Fluency Test in persons aged 35 years or olderAdded value of screening for CKD among the elderly or persons with low socioeconomic statusUrinary albumin excretion in healthy adults: a cross sectional study of 24-hour versus timed overnight samples and impact of GFR and other personal characteristicsSerum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive Protein.Are Microalbuminuria and Elevated 24 H Urinary Microalbumin Excretion within Normal Range Associated with Metabolic Syndrome in Chinese Adults?Influence of urine creatinine on the relationship between the albumin-to-creatinine ratio and cardiovascular events.Early chronic kidney disease: diagnosis, management and models of careCKD and hospitalization in the elderly: a community-based cohort study in the United Kingdom.Agreement between Computerized and Human Assessment of Performance on the Ruff Figural Fluency TestPeroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality.Consecutive first-morning urine samples to measure change in the albumin-to-creatinine ratio: a pilot study of a home urine collection protocol.Creatinine excretion rate and mortality in type 2 diabetes and nephropathy.11. Laboratory Standards in the Diagnosis and Monitoring of Therapy.Influence of urine creatinine concentrations on the relation of albumin-creatinine ratio with cardiovascular disease events: the Multi-Ethnic Study of Atherosclerosis (MESA)Socioeconomic measures and CKD in the United States and The Netherlands
P2860
Q30582848-E7ADB6DF-A51F-4330-B435-1AE1F0046C16Q33600896-593AD77B-24F3-44AC-83D0-F10FEB1C94F7Q33707463-5176BE58-B15E-40DB-A17F-10B8DCFFC78FQ33828539-80334C94-7454-4CC3-ADAB-7A67B7810B33Q33888418-63D37D7A-59EB-4049-81CC-DCEC2E0984C3Q33901943-2EA4FAFD-DFC7-415C-A301-BCC67E6510ECQ33946198-690B9A0A-8329-4B20-8E97-5F8D1FE296EDQ33950593-6C57F21D-932A-4338-BF42-8C07F8D0FDA5Q33990767-05CDE462-C511-4632-9DD1-C765BCBE7C59Q34081529-12DEEEAC-6E96-495A-829F-F9328E701D36Q34124213-241381B8-6AB3-4412-A7FC-89AB0100D8CFQ34297101-FD4557B2-2733-4F1A-A29F-7122B3CB5ED1Q34314185-41C9B9DE-409A-4C63-BF70-C872FB735AB9Q34387871-65A49EC1-DC05-4B01-B6D2-736BEA18DB6DQ34402024-F8D74085-2032-41C1-A67A-393740E6C1DFQ34405328-9D60D4DA-25DA-4944-9B7F-9C344C700934Q34531926-422A2CEC-B7C6-4AED-B9A6-6726CC2075B3Q34568807-52035407-4447-484F-B1C7-D2432DE1623FQ34749180-FD1F2B98-C6F8-4298-BC95-763782B29D05Q34776124-AAB4FD68-855F-49E7-8819-1BE63D06E77FQ35030627-0AD97108-D4CC-4A39-A5EC-C7F851D5ED9CQ35075501-BB594270-7373-4EC1-9A7C-8A63B91FACE4Q35136767-3C225801-0D2B-49EF-AFB4-B3F0C1765623Q35144449-739FA74A-F4E6-4CAD-8AA7-5BA8D27DBB9BQ35184307-DB53E173-54EA-42ED-81F9-15D84D919BB0Q35208218-8CE7B69F-3844-488A-8F64-7993427619E3Q35278606-641B43F2-64AA-4E10-AFAB-7165E282E1F5Q35548313-7A451D4B-BA2C-437D-B165-CE19A549E430Q35689480-142256F1-0DFB-4548-A497-F22703EB9011Q35778761-44C56E1D-5169-4CA2-ACCC-6B3922F2B550Q35860711-B8BDD94E-CA98-4079-9B00-E781669694D2Q35938045-3E6A4DB0-444B-4A38-AE9C-601CBD9AF4CCQ36084524-520C9702-EFBF-4978-94BD-440854EF5A19Q36142377-0D1E7E8A-F20A-4FA1-81F9-0DB9C2614C2BQ36522598-A773DBD6-A099-40BE-AFEF-D1B7853BA0C7Q36525946-B34485C1-0AC9-4D6C-A54B-12A5DBA447F2Q36868219-06A6DE92-C023-44B7-80C7-59FF11BF3F87Q37155232-55C3DE7A-A6A1-4B07-8605-67BE43F0E1A7Q37198676-80CF52C5-A5C6-425B-9AFB-AA9AA62EF266Q37212395-C413BA0E-EE89-4C24-BBCB-3C843FC144AA
P2860
Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Albuminuria assessed from firs ...... cular morbidity and mortality.
@en
Albuminuria assessed from firs ...... cular morbidity and mortality.
@nl
type
label
Albuminuria assessed from firs ...... cular morbidity and mortality.
@en
Albuminuria assessed from firs ...... cular morbidity and mortality.
@nl
prefLabel
Albuminuria assessed from firs ...... cular morbidity and mortality.
@en
Albuminuria assessed from firs ...... cular morbidity and mortality.
@nl
P2093
P2860
P356
P1476
Albuminuria assessed from firs ...... cular morbidity and mortality.
@en
P2093
Auke H Brantsma
Dick de Zeeuw
Hiddo J Lambers Heerspink
PREVEND Study Group
Paul E de Jong
Ron T Gansevoort
Stephan J L Bakker
P2860
P304
P356
10.1093/AJE/KWN209
P407
P577
2008-09-05T00:00:00Z